🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Egypt / NCT07079917
Starting soon Not applicable

Alveolar Ridge Augmentation Using Minimally Invasive Subperiosteal Tunneling With Xenogenic Bone Graft and PRF

NCT07079917 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2025-08-01
Last updated
2025-07-23

Condition(s) studied

Alveolar Bone Loss

Investigational drug(s) / intervention(s)

subperiosteal tunneling for horizontal alveolar ridge augmentationconventional alveolar ridge augmentation

subperiosteal tunneling for horizontal alveolar ridge augmentation: subperiosteal dissection through horizontal incision only

conventional alveolar ridge augmentation: horizontal alveolar ridge augmentation through trapezoidal flap

Study summary

surgical horizontal augmentation for maxillary alveolar ridge using minimally invasive subperiosteal tunneling in comparison to conventional surgical technique

Eligibility

Sex
ALL
Min age
18 Years
Max age
60 Years
Healthy volunteers
No
Inclusion Criteria: * Adults over 18 years old seeking an implant-supported restoration with deficient horizontal posterior maxillary alveolar ridge, at area of one or two missed teeth of less than 5 mm buccolingual width. * Minimum vertical height of 8 mm. * Gingival tissue of healthy adequate keratinization, more than 2mm. Exclusion Criteria: * The presence of uncontrolled diabetes or any other systemic condition which may complicate the surgical procedure or interfere with bone healing * Radiotherapy to the head and neck region * Chemotherapy within the last 12 months * Uncontrolled periodontitis * Smoking * Bisphosphonate therapy * Pregnancy * Presence of periapical infection or lesion

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Fayoum University Al Fayyum Egypt

More Fayoum University trials in Egypt

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07079917 on ClinicalTrials.gov ↗ ← All trials in Egypt